Beyond standard tirzepatide monitoring (A1c, kidney function, lipids), autoimmune patients should track disease-specific inflammatory markers at baseline, 4 weeks, 12 weeks, and quarterly thereafter
The Deprescribing Model Unlike practitioners who prescribe GLP-1s for indefinite use, providers like Eliszewski and Class set out with deprescribing in mind
With Sterile Water: There is no preservative
47 AF results in loss of atrial contribution to LV diastolic filling, RR interval irregularity and atrial myopathy
Conclusion: The GLP-1 Peptide Sequencing Analytical Technique is a cornerstone of modern peptide drug development, and HRMS stands at the forefront of this field
Patience and consistency are essential for achieving meaningful and lasting results